日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Infection-related complications during treatment for childhood acute lymphoblastic leukemia

儿童急性淋巴细胞白血病治疗期间的感染相关并发症

Inaba, H; Pei, D; Wolf, J; Howard, S C; Hayden, R T; Go, M; Varechtchouk, O; Hahn, T; Buaboonnam, J; Metzger, M L; Rubnitz, J E; Ribeiro, R C; Sandlund, J T; Jeha, S; Cheng, C; Evans, W E; Relling, M V; Pui, C-H

Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy

微小残留病灶对接受反应适应性治疗的不同亚型急性淋巴细胞白血病患儿的临床影响

Pui, C-H; Pei, D; Raimondi, S C; Coustan-Smith, E; Jeha, S; Cheng, C; Bowman, W P; Sandlund, J T; Ribeiro, R C; Rubnitz, J E; Inaba, H; Gruber, T A; Leung, W H; Yang, J J; Downing, J R; Evans, W E; Relling, M V; Campana, D

A revised definition for cure of childhood acute lymphoblastic leukemia

儿童急性淋巴细胞白血病治愈的修订定义

Pui, C H; Pei, D; Campana, D; Cheng, C; Sandlund, J T; Bowman, W P; Hudson, M M; Ribeiro, R C; Raimondi, S C; Jeha, S; Howard, S C; Bhojwani, D; Inaba, H; Rubnitz, J E; Metzger, M L; Gruber, T A; Coustan-Smith, E; Downing, J R; Leung, W H; Relling, M V; Evans, W E

Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study

FKBP5基因变异对儿童急性髓系白血病患者临床反应的影响:一项初步研究

Mitra, A K; Crews, K; Pounds, S; Cao, X; Downing, J R; Raimondi, S; Campana, D; Ribeiro, R C; Rubnitz, J E; Lamba, J K

IDH1 and IDH2 mutations in pediatric acute leukemia.

儿童急性白血病中的 IDH1 和 IDH2 突变

Andersson A K, Miller D W, Lynch J A, Lemoff A S, Cai Z, Pounds S B, Radtke I, Yan B, Schuetz J D, Rubnitz J E, Ribeiro R C, Raimondi S C, Zhang J, Mullighan C G, Shurtleff S A, Schulman B A, Downing J R

Clinical consequences of hyperglycemia during remission induction therapy for pediatric acute lymphoblastic leukemia

儿童急性淋巴细胞白血病缓解诱导治疗期间高血糖的临床后果

Roberson, J R; Spraker, H L; Shelso, J; Zhou, Y; Inaba, H; Metzger, M L; Rubnitz, J E; Ribeiro, R C; Sandlund, J T; Jeha, S; Pui, C-H; Howard, S C

Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study

CD33编码多态性与儿童急性髓系白血病患者对吉妥珠单抗奥佐米星的反应:一项初步研究

Lamba, J K; Pounds, S; Cao, X; Downing, J R; Campana, D; Ribeiro, R C; Pui, C-H; Rubnitz, J E

Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1

t(1;19)/TCF3-PBX1 前 B 细胞白血病中枢神经系统复发风险增加

Jeha, S; Pei, D; Raimondi, S C; Onciu, M; Campana, D; Cheng, C; Sandlund, J T; Ribeiro, R C; Rubnitz, J E; Howard, S C; Downing, J R; Evans, W E; Relling, M V; Pui, C-H

Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia

急性淋巴细胞白血病治疗过程中急性髓系白血病的分子出现

Blanco, J G; Dervieux, T; Edick, M J; Mehta, P K; Rubnitz, J E; Shurtleff, S; Raimondi, S C; Behm, F G; Pui, C H; Relling, M V

p27KIP1 deletions in childhood acute lymphoblastic leukemia

儿童急性淋巴细胞白血病中的p27KIP1缺失

Komuro, H; Valentine, M B; Rubnitz, J E; Saito, M; Raimondi, S C; Carroll, A J; Yi, T; Sherr, C J; Look, A T